NASDAQ:BEAT

Biotelemetry Stock Insider Trading

Healthcare > Medical - Healthcare Information Services

Buy BEAT

*Your capital is at risk

$0.89

+0.0145 (+1.66%)

At Close: Jun 03, 2026

BioTelemetry Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 30.09. In total, the insiders bought 4.36M and sold 397.44K BEAT shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	30.09
● Buy	4.36M shares
● Sell	397.44K shares
69% Buy Activity Negligible or No Correlation
Buy Signal Medium Confidence Apr 16, 2026 Analysis Breakdown: Supported by a positive Insider Power Score of 30.09. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Apr 16, 2026 Buy	Common Stock P-Purchase	Ferrari Richard Director	Director	57 500 Value: $46.0K
Apr 16, 2026 Buy	Common Stock P-Purchase	Strome Mark E Director	Director	750 000 Value: $600.0K
Apr 16, 2026 Buy	Common Stock P-Purchase	Vajdic Branislav Director	Director	31 250 Value: $25.0K
Apr 16, 2026 Buy	Common Stock P-Purchase	Jaff Michael R Director	Director	31 250 Value: $25.0K
Apr 16, 2026 Buy	Common Stock P-Purchase	Elfrink Willem Director	Director	187 500 Value: $150.0K
Apr 16, 2026 Buy	Common Stock P-Purchase	Cruickshank Tim CFO	C-Suite Officer	31 250 Value: $25.0K
Apr 16, 2026 Buy	Common Stock P-Purchase	Ferrari Richard Director	Director	62 500 Value: $50.0K
Apr 16, 2026 Buy	Common Stock P-Purchase	Eno Robert Paul President	CEO / President	12 500 Value: $10.0K
Apr 16, 2026 Buy	Common Stock P-Purchase	Ortigas-wedekind Marga Director	Director	25 000 Value: $20.0K
Feb 09, 2026 Buy	Common Stock A-Award	Nelson Kenneth Warwick Iii Director	Director	17 241 Value: $24.7K
Feb 09, 2026 Buy	Common Stock (right to buy) A-Award	Cruickshank Tim CFO	C-Suite Officer	53 104 Value: $77.0K
Feb 09, 2026 Buy	Common Stock (right to buy) A-Award	Vajdic Branislav President	CEO / President	61 932 Value: $89.8K
Feb 09, 2026 Buy	Common Stock A-Award	Jaff Michael R Director	Director	20 689 Value: $29.6K
Feb 09, 2026 Buy	Common Stock(right to buy) A-Award	Ortigas-wedekind Marga Director	Director	44 827 Value: $64.1K
Feb 09, 2026 Buy	Common Stock A-Award	Ferrari Richard Director	Director	50 000 Value: $71.5K
Feb 09, 2026 Buy	Common Stock (right to buy) A-Award	Strome Mark E 10 Percent Owner	10% Owner	41 380 Value: $59.2K
Feb 09, 2026 Buy	Common Stock (right to buy) A-Award	Elfrink Willem Director	Director	51 724 Value: $74.0K
Feb 09, 2026 Buy	Common Stock (right to buy) A-Award	De Urioste George Director	Director	51 724 Value: $74.0K
Feb 09, 2026 Buy	Common Stock (right to buy) A-Award	Eno Robert Paul President	CEO / President	55 172 Value: $80.0K
Dec 18, 2025 Sell	Common Stock S-Sale	De Urioste George Director	Director	33 185 Value: $93.9K
Dec 17, 2025 Sell	Common Stock S-Sale	Strome Mark E 10 Percent Owner	10% Owner	250 000 Value: $895.0K
Dec 17, 2025 Sell	Common Stock S-Sale	De Urioste George Director	Director	23 961 Value: $88.2K
Sep 30, 2025 Buy	Common Stock J-Other	Cruickshank Tim Officer	Officer	0 Value: $0
Sep 30, 2025 Buy	Common Stock J-Other	Cruickshank Tim Officer	Officer	0 Value: $0
Sep 30, 2025 Buy	Common Stock J-Other	Eno Robert Paul Officer	Officer	0 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT BIOTELEMETRY

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the...

Read Full Profile Here